New This Month | New This Year | Abstract | TRITE Statistics | Disclaimer

Results - FULL MEDLINE:

Pathways to primary neurodegenerative disease. J Hardy Mayo Clin Proc 1999 Aug; 74(8)835-7. Score: 0.327 Oxidative damage in neurodegenerative disease. P Jenner Lancet 1994 Sep; 344(8925)796-8. Score: 0.327 Neurodegenerative disease research in the 21st century. Kelly R Bales Drug Discov Today 2004 Jul; 9(13)553-6. Score: 0.327 Neurodegenerative disorders. R Kale BMJ 2001 Oct; 323(7318)879-80. Score: 0.313 Neurodegenerative disorders. P Verdru Neurology 1992 Jul; 42(7)1431; author reply 1432. Score: 0.313 Neurodegenerative disorders. F Ovsiew Neurology 1992 Jul; 42(7)1431; author reply 1432. Score: 0.313 Neurodegenerative disorders. V M Berginer Neurology 1992 Jul; 42(7)1431-2. Score: 0.313 Neurodegenerative diseases. Part II: transmissible neurodegenerative disorders. Proceedings of a symposium. Ocho Rios, Jamaica, February 28-March 5, 1993. Mol Neurobiol 1994 Apr-Jun; 8(2-3)79-196. Score: 0.308 Neurodegenerative disease: neuron protection agency. Harry T Orr Nature 2004 Oct; 431(7010)747-8. Score: 0.303 Sex-linked neurodegenerative disease associated with monilethrix. P F Bray Pediatrics 1965 Sep; 36(3)417-20. Score: 0.303 NPY and chronic neurodegenerative disease. Carol A Colton ... Michael P Vitek EXS 2006 ; (95)223-44. Score: 0.303 [Prion disease: a new class of neurodegenerative disorders] F T Wieringa Ned Tijdschr Geneeskd 1995 May; 139(18)944. Score: 0.303 VEGF's Surprise Role in Neurodegenerative Disease. Vicki Brower J Natl Cancer Inst 2003 Oct; 95(19)1426. Score: 0.303 Nutrient and toxin interactions in neurodegenerative disease. P H Evans Proc Nutr Soc 1994 Jul; 53(2)431-42. Score: 0.303 Progressive neurodegenerative disease and pain. Saloni Shah ... Steven Tear IDrugs 2005 Dec; 8(12)957-9. Score: 0.303 Small steps towards treatment of incurable neurodegenerative diseases. Hugo Geerts Drug Discov Today 2005 Mar; 10(6)391-3. Score: 0.301 Insulin and neurodegenerative disease: shared and specific mechanisms. Suzanne Craft ... G Stennis Watson Lancet Neurol 2004 Mar; 3(3)169-78. Score: 0.288 Nitric oxide in neurodegenerative diseases. Baolu Zhao Front Biosci 2005 Jan; 10()454-61. Score: 0.288 Neurodegenerative disease. S E Browne IDrugs 1999 Jan; 2(1)4-6. Score: 0.285 Towards gene therapy of neurodegenerative disease. H J Federoff ... M Atkinson Prog Brain Res 1998 ; 117()503-10. Score: 0.283 Glycine and neurodegenerative disease. R J Lane ... J de Belleroche Lancet 1991 Mar; 337(8743)732-3. Score: 0.283 Aggregates in neurodegenerative disease: crowds and power? P B Tran ... R J Miller Trends Neurosci 1999 May; 22(5)194-7. Score: 0.283 Applications of laser capture microdissection in the study of neurodegenerative disease. David G Standaert Arch Neurol 2005 Feb; 62(2)203-5. Score: 0.283 Roles of the proteasome in neurodegenerative disease: refining the hypothesis. Mark R Cookson Ann Neurol 2004 Sep; 56(3)315-6. Score: 0.283 Caspases: a treatment target for neurodegenerative disease? D M Holtzman ... M Deshmukh Nat Med 1997 Sep; 3(9)954-5. Score: 0.283 Glutamate toxicity in chronic neurodegenerative disease. E Lancelot ... M F Beal Prog Brain Res 1998 ; 116()331-47. Score: 0.283 Strategies for evaluating the child with suspected neurodegenerative disease. J H Menkes Monatsschr Kinderheilkd 1989 May; 137(5)254-6. Score: 0.283 Specific neuroimmunophilin ligands to treat neurodegenerative disease. L Fletcher Mol Med Today 1997 Dec; 3(12)518. Score: 0.283 Creutzfeldt-Jakob disease. A fatal neurodegenerative transmissible disorder. B K Bailes AORN J 1990 Nov; 52(5)976-7, 980-5. Score: 0.283 Inflammation in neurodegenerative disease: good, bad, or irrelevant? L S Honig Arch Neurol 2000 Jun; 57(6)786-8. Score: 0.283 Parkinson's disease: a neurodegenerative disease particularly amenable to gene therapy. M C Bohn Mol Ther 2000 Jun; 1(6)494-6. Score: 0.282 Alpha-synuclein and neurodegenerative diseases. M Goedert Nat Rev Neurosci 2001 Jul; 2(7)492-501. Score: 0.280 Neurodegenerative causes of myoclonus. Philip D Thompson Adv Neurol 2002 ; 89()31-4. Score: 0.280 [Aged-related neurodegenerative diseases] F F Cruz-Sánchez Rev Fac Cien Med Univ Nac Cordoba 2000 ; 57(1)9-29. Score: 0.280 Neurodegenerative diseases and transglutaminase. L Lorand Proc Natl Acad Sci U S A 1996 Dec; 93(25)14310-3. Score: 0.280 [Treatment of neurodegenerative diseases] M Peschanski Pathol Biol (Paris) 2000 May; 48(4)447-8. Score: 0.280 Caspases and neurodegenerative diseases. M Hafezparast Mol Med Today 2000 Sep; 6(9)338. Score: 0.280 [Progress in the study of neurodegenerative diseases] F Salamanca-Gómez Gac Med Mex 2001 Sep-Oct; 137(5)487-8. Score: 0.280 Neurodegenerative tauopathy in the worm. Michel Goedert Proc Natl Acad Sci U S A 2003 Aug; 100(17)9653-5. Score: 0.280 Vision and neurodegenerative diseases. I Bodis-Wollner Vision Res 1997 Dec; 37(24)3441-3. Score: 0.280 Neurodegenerative disorders. M R Filling-Katz ... N W Barton Neurology 1992 Jul; 42(7)1431; author reply 1432. Score: 0.280 Prions and neurodegenerative diseases. S B Prusiner N Engl J Med 1987 Dec; 317(25)1571-81. Score: 0.280 Defining neurodegenerative diseases. Adrian Williams BMJ 2002 Jun; 324(7352)1465-6. Score: 0.280 Memory and language in neurodegenerative diseases. G Dalla Barba ... F Boller Curr Opin Neurol 1998 Oct; 11(5)429-33. Score: 0.276 Activated microglia: the silent executioner in neurodegenerative disease? S H Appel ... E P Simpson Curr Neurol Neurosci Rep 2001 Jul; 1(4)303-5. Score: 0.267 Using cognitive performance to investigate neurodegenerative disease. George J Spilich ... Davor Janculjak Clin Neurol Neurosurg 2002 Jul; 104(3)228-30. Score: 0.267 Neurotrophins in neurodegenerative disease: theoretical issues and clinical trials. L Olson Neurochem Int 1994 Jul; 25(1)1-3. Score: 0.267 Narcolepsy: a neurodegenerative disease of the hypocretin system? A N van den Pol Neuron 2000 Sep; 27(3)415-8. Score: 0.267 Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences? Gjumrakch Aliev J Alzheimers Dis 2002 Dec; 4(6)513-6. Score: 0.267 Cycads, designer drugs, free radicals and neurodegenerative disease. J D Mitchell Arch Toxicol Suppl 1992 ; 15()130-9. Score: 0.267 Aluminum and neurodegenerative disease: therapeutic implications. D R McLachlan ... M F VanBerkum Am J Kidney Dis 1985 Nov; 6(5)322-9. Score: 0.267 Immune-mediated cell death in neurodegenerative disease. S H Appel ... W D Le Adv Neurol 1996 ; 69()153-9. Score: 0.267 Apoptosis in neurodegenerative disorders. L Stefanis ... L A Greene Curr Opin Neurol 1997 Aug; 10(4)299-305. Score: 0.266 Protein precipitation: a common etiology in neurodegenerative disorders? A Kakizuka Trends Genet 1998 Oct; 14(10)396-402. Score: 0.266 Neuro-ophthalmic manifestations of neurodegenerative disease. Victoria S Pelak ... Deborah A Hall Ophthalmol Clin North Am 2004 Sep; 17(3)311-20, v. Score: 0.266 Neurodegenerative diseases. A J Hannan IDrugs 2001 Jan; 4(1)6-8. Score: 0.264 New insights on the pathogenesis of neurodegenerative disorders. F Piccoli ... R Guarneri Acta Neurol (Napoli) 1992 Aug-Dec; 14(4-6)455-68. Score: 0.259 Coenzyme Q10 in neurodegenerative diseases. Clifford W Shults Curr Med Chem 2003 Oct; 10(19)1917-21. Score: 0.258 Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models. Jose-Luis González De Aguilar ... Jean-Philippe Loeffler Neuroendocrinology 2003 Nov; 78(5)244-52. Score: 0.258 Immunotherapy as a therapeutic treatment for neurodegenerative disorders. Anthony R White ... Simon H Hawke J Neurochem 2003 Nov; 87(4)801-8. Score: 0.257 Management of neurodegenerative disorders. Hosp Med 1999 Jul; 60(7)509-15. Score: 0.256 An overview of the pathophysiology of neurodegenerative disorders. Catherine Willner Altern Ther Health Med 2004 Jul-Aug; 10(4)26-34; quiz 35, 96. Score: 0.256 Apoptosis and caspases in neurodegenerative diseases. Robert M Friedlander N Engl J Med 2003 Apr; 348(14)1365-75. Score: 0.256 [Proteasone, ubiquitine and neurodegenerative diseases] J M Giménez-Amaya Neurologia 1999 Apr; 14(4)195-7. Score: 0.256 What's new in...neurogenetics? Focus on neurodegenerative disorders. M Suri Eur J Paediatr Neurol 2001 ; 5(6)221-4. Score: 0.256 CNS mitochondria in neurodegenerative disorders. Janet M Dubinsky Antioxid Redox Signal 2005 Sep-Oct; 7(9-10)1089-91. Score: 0.256 Themed issue: neurodegenerative diseases. D B Ramsden Mol Pathol 2001 Dec; 54(6)361. Score: 0.256 Glutamine repeats and neurodegenerative diseases. M F Perutz Brain Res Bull 1999 Nov 15-Dec; 50(5-6)467. Score: 0.256 Treating neurodegenerative diseases. Leslie J Findley ... Mary G Baker BMJ 2002 Jun; 324(7352)1466-7. Score: 0.256 Scrapie and human neurodegenerative diseases. P K Lewin CMAJ 1990 May; 142(9)928. Score: 0.256 New approaches to therapy for neurodegenerative diseases. D E Schmechel South Med J 1991 May; 84(5 Suppl 1)S11-23. Score: 0.256 Viewpoint: reductionism and the study of neurodegenerative disorders. L M Shulman Mov Disord 1997 Jan; 12(1)118-9. Score: 0.256 Neurodegenerative diseases. Origins of instability. R R Sinden Nature 2001 Jun; 411(6839)757-8. Score: 0.256 Proteolytic dysfunction in neurodegenerative disorders. Kevin St P McNaught Int Rev Neurobiol 2004 ; 62()95-119. Score: 0.256 Trinucleotide-repeat expansions and neurodegenerative diseases. A J Hannan Trends Neurosci 1995 Oct; 18(10)440. Score: 0.256 [Thioredoxin and neurodegenerative diseases] Lei Zhao ... Jing Gao Sheng Li Ke Xue Jin Zhan 2002 Jan; 33(1)74-6. Score: 0.256 Sleep in aging and neurodegenerative diseases. Madeleine M Grigg-Damberger Suppl Clin Neurophysiol 2004 ; 57()508-20. Score: 0.256 [Introduction. Neurodegenerative diseases and sleep] M Billiard Rev Neurol (Paris) 2003 Nov; 159(11 Suppl)6S56-8. Score: 0.256 Cholinergic receptors and neurodegenerative diseases. F Gualtieri Pharm Acta Helv 2000 Mar; 74(2-3)85-9. Score: 0.256 [Neurofibrillary tangles and neurodegenerative disease] Akihiko Takashima Seikagaku 2002 Jun; 74(6)461-70. Score: 0.256 Vitamin E in neurodegenerative diseases. Humaira M Khan ... Mohammad Saeed J Coll Physicians Surg Pak 2004 Jun; 14(6)386. Score: 0.256 Molecular basis of the neurodegenerative disorders. J B Martin N Engl J Med 1999 Jun; 340(25)1970-80. Score: 0.256 Prana Biotechnology, Limited: metal attenuation in the treatment of neurodegenerative disease. Alice M McCarthy Chem Biol 2004 Nov; 11(11)1473-4. Score: 0.253 Neurodegenerative disease. Using the fruit fly to model tau malfunction. D Ferber Science 2001 Jun; 292(5524)1983-4. Score: 0.253 Neurodegenerative tauopathies: human disease and transgenic mouse models. V M Lee ... J Q Trojanowski Neuron 1999 Nov; 24(3)507-10. Score: 0.253 [Cytoskeletal changes in Alzheimer's disease and other neurodegenerative disorders] R Astarloa ... J C Alvarez-Cermeño Neurologia 1990 Feb; 5(2)52-61. Score: 0.253 Cerebral microischemia as a potential precipitant of the neurodegenerative cascade of Alzheimer's disease. J S Richardson Ann N Y Acad Sci 1997 Sep; 826()437-9. Score: 0.253 The first miracle in neurodegenerative disease: the discovery of oral levodopa. J H Kordower ... C G Goetz Brain Res Bull 1999 Nov 15-Dec; 50(5-6)377-8. Score: 0.253 The impact of systemic infection on the progression of neurodegenerative disease. V Hugh Perry ... Colm Cunningham Nat Rev Neurosci 2003 Feb; 4(2)103-12. Score: 0.253 Glutamine repeats as polar zippers: their role in inherited neurodegenerative disease. M F Perutz Mol Med 1995 Nov; 1(7)718-21. Score: 0.253 N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder. A Verma ... S K Kulkarni Ann N Y Acad Sci 1995 Sep; 765()327. Score: 0.253 Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease. Dennis W Dickson J Clin Invest 2002 Nov; 110(10)1403-5. Score: 0.253 Neural transplantation in neurodegenerative disease: current status and new directions. Introduction. J Gray Novartis Found Symp 2000 ; 231()1-6. Score: 0.253 Unstable expansion of triplet repeats as a new disease mechanism for neurodegenerative diseases. S Tsuji Jpn J Hum Genet 1996 Sep; 41(3)279-90. Score: 0.253 Energetics in the pathogenesis of neurodegenerative diseases. M F Beal Trends Neurosci 2000 Jul; 23(7)298-304. Score: 0.250 New prospects and strategies for drug target discovery in neurodegenerative disorders. Brian S Hilbush ... Floyd E Bloom NeuroRx 2005 Oct; 2(4)627-37. Score: 0.250 Failed to fetch article title! Article may not be available. Score: 0.247 Mixed dementia: Alzheimer's and cerebrovascular disease. Kenneth Rockwood Int Psychogeriatr 2003 ; 15 Suppl 1()39-46. Score: 0.247 The genetic epidemiology of neurodegenerative disease. Lars Bertram ... Rudolph E Tanzi J Clin Invest 2005 Jun; 115(6)1449-57. Score: 0.244 The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. R G Feldman ... M H Ratner Curr Opin Neurol 1999 Dec; 12(6)725-31. Score: 0.244 The role of metals in neurodegenerative diseases. L M Sayre ... M A Smith Cell Mol Biol (Noisy-le-grand) 2000 Jun; 46(4)731-41. Score: 0.243 Neurodegenerative diseases: an overview of environmental risk factors. Rebecca C Brown ... Babasaheb R Sonawane Environ Health Perspect 2005 Sep; 113(9)1250-6. Score: 0.242 Neurodegenerative disease: a different view of diagnosis. J Hardy ... K Gwinn-Hardy Mol Med Today 1999 Dec; 5(12)514-7. Score: 0.242 Demented flies? Using Drosophila to model human neurodegenerative diseases. K Michno ... G L Boulianne Clin Genet 2005 Jun; 67(6)468-75. Score: 0.241 Nosological significance of retinopathies in neurodegenerative disorders with emphasis on Batten disease. A A Hussain ... J Marshall J Inherit Metab Dis 1993 ; 16(2)267-71. Score: 0.241 Polyglutamine expansion neurodegenerative disease. K H Fischbeck Brain Res Bull 2001 Oct-Nov 1; 56(3-4)161-3. Score: 0.241 Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop. S Fahn ... T N Chase Mov Disord 1998 Sep; 13(5)759-67. Score: 0.241 Use of genetically engineered mice as models for understanding human neurodegenerative disease. J K Andersen ... O P Jurma J Am Geriatr Soc 1996 Jun; 44(6)717-22. Score: 0.241 What transgenic mice tell us about neurodegenerative disease. M E Gurney Bioessays 2000 Mar; 22(3)297-304. Score: 0.240 Might environmental factors contribute to neurodegenerative diseases? K F Tipton Biochem Soc Trans 1995 May; 23(2)429-35. Score: 0.237 A role for glutamate transporters in neurodegenerative diseases. Davide Trotti Adv Exp Med Biol 2002 ; 513()225-48. Score: 0.237 [The ubiquitin-proteasome system and neurodegenerative disease] K Tanaka No To Shinkei 2001 Oct; 53(10)935-42. Score: 0.237 Proteolysis problems implicated in neurodegenerative diseases. J Bradbury Lancet 2001 May; 357(9269)1679. Score: 0.237 [CDK5 and neurodegenerative disease] Ying-Peng Wang ... Zhi-Ren Rao Sheng Li Ke Xue Jin Zhan 2004 Jan; 35(1)45-8. Score: 0.237 [Glial cytoskeletal abnormalities in neurodegenerative diseases] K Ikeda No To Shinkei 1996 Oct; 48(10)885-94. Score: 0.237 Mitochondria, brain aging and neurodegenerative disorders. A Toledano Aging (Milano) 1993 Dec; 5(6)459-61. Score: 0.237 Inherited neurodegenerative diseases and transgenic models. D R Borchelt Lab Anim Sci 1998 Dec; 48(6)604-10. Score: 0.237 Advances in neuroprotection research for neurodegenerative diseases. Mario E Götz ... Peter Riederer Adv Exp Med Biol 2004 ; 541()1-19. Score: 0.237 The role of apoptosis in neurodegenerative diseases. I Hajimohamadreza ... J M Treherne Prog Drug Res 1997 ; 48()55-98. Score: 0.237 [Vitamin E and neurodegenerative diseases] M Dib ... V Meininger Rev Neurol (Paris) 2003 Jul; 159(6-7 Pt 1)618-21. Score: 0.237 Transglutaminases in neurodegenerative disorders. Craig D C Bailey ... Gail V W Johnson Prog Exp Tumor Res 2005 ; 38()139-57. Score: 0.237 [Epidemiology of neurodegenerative disorders : the example of dementia] P Amouyel Ann Biol Clin (Paris) 2000 May-Jun; 58(3)345-9. Score: 0.237 Apoptosis and human neurodegenerative diseases. Mark D Berry ... Alan A Boulton Prog Neuropsychopharmacol Biol Psychiatry 2003 Apr; 27(2)197-8. Score: 0.237 Contributory mechanisms in the causation of neurodegenerative disorders. G J Lees Neuroscience 1993 May; 54(2)287-322. Score: 0.237 [Genetic defects in neurodegenerative diseases] B Davidson ... D Nass Harefuah 1997 Apr; 132(7)481-5. Score: 0.237 Genetics of neurodegenerative disorders. Calogero Caruso ... Federico Licastro N Engl J Med 2003 Jul; 349(2)193-4; author reply 193-4. Score: 0.237 Tangles and neurodegenerative disease--a surprising twist. Rudolph E Tanzi N Engl J Med 2005 Oct; 353(17)1853-5. Score: 0.237 Neurodegenerative diseases in pediatric neurology. Introduction. P R Dyken Semin Pediatr Neurol 1996 Dec; 3(4)257-9. Score: 0.237 Rising prevalence of neurodegenerative diseases worldwide. K Kondo Intern Med 1996 Apr; 35(4)238. Score: 0.237 Neurodegenerative disorders and hyperaldosteronism. A P Simopoulos ... F C Bartter J Pediatr 1971 Oct; 79(4)633-41. Score: 0.237 The role of apoptosis in neurodegenerative diseases. P Desjardins ... S Ledoux Metab Brain Dis 1998 Jun; 13(2)79-96. Score: 0.237 Therapeutic potential of neurotrophic factors in neurodegenerative diseases. Yossef S Levy ... Daniel Offen BioDrugs 2005 ; 19(2)97-127. Score: 0.235 Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Miratul M K Muqit ... Mel B Feany Nat Rev Neurosci 2002 Mar; 3(3)237-43. Score: 0.235 Transgenic models of neurodegenerative diseases. M K Lee ... D L Price Curr Opin Neurobiol 1996 Oct; 6(5)651-60. Score: 0.233 Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? Michel Dib ... Claude Desnuelle J Neurol 2002 Apr; 249(4)367-74. Score: 0.232 Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease. Bénédicte C Charrin ... Sandrine Humbert Pathol Biol (Paris) 2005 May; 53(4)189-92. Score: 0.231 [Familial neurodegenerative disease in an Israeli Arab family] D Harel ... H Dar Harefuah 1986 Feb; 110(3)117-9. Score: 0.231 Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. J R James ... A Nordberg Behav Genet 1995 Mar; 25(2)149-59. Score: 0.231 Neurodegenerative diseases of infancy and childhood. P Dyken ... N Krawiecki Ann Neurol 1983 Apr; 13(4)351-64. Score: 0.231 Superior oblique myokymia in a case of hereditary metabolic neurodegenerative disease (adrenoleucodystrophy). A Neetens ... J J Martin Bull Soc Belge Ophtalmol 1983 Nov; 208 Pt 1()219-23. Score: 0.231 [Prion disease: a new class of neurodegenerative disorders] W A van Gool ... P A Bolhuis Ned Tijdschr Geneeskd 1995 Mar; 139(12)606-13. Score: 0.231 Proceedings of the Symposium on Novel Therapeutic Opportunities for Neurodegenerative Disease. September 12-13, 2002, Aveiro, Portugal. J Mol Neurosci 2004 ; 23(1-2)1-147. Score: 0.231 Neurodegenerative diseases: pathology and the advantage of single-cell profiling. James E Galvin Neurochem Res 2004 Jun; 29(6)1041-51. Score: 0.230 Sleep and quantitative EEG in neurodegenerative disorders. Dominique Petit ... Jacques Montplaisir J Psychosom Res 2004 May; 56(5)487-96. Score: 0.230 Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. D A Butterfield ... J Kanski Mech Ageing Dev 2001 Jul; 122(9)945-62. Score: 0.230 The GSK3 beta signaling cascade and neurodegenerative disease. Michael D Kaytor ... Harry T Orr Curr Opin Neurobiol 2002 Jun; 12(3)275-8. Score: 0.228 Etiology of (CAG)n triplet repeat neurodegenerative diseases such as Huntington's disease is connected to stimulation of glutamate receptors. K M Fischer Med Hypotheses 1997 May; 48(5)393-8. Score: 0.228 From target identification to drug screening assays for neurodegenerative diseases. Chiara Zuccato ... Dorotea Rigamonti Pharmacol Res 2005 Sep; 52(3)245-51. Score: 0.228 Therapeutic potential in Alzheimer disease. A D Cash ... M A Smith Curr Med Chem 2002 Sep; 9(17)1605-10. Score: 0.227 Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Jing Zhang ... Thomas J Montine J Alzheimers Dis 2005 ; 8(4)377-86. Score: 0.227 Myoclonus and neurodegenerative disease--what's in a name? John N Caviness Parkinsonism Relat Disord 2003 Mar; 9(4)185-92. Score: 0.226 Genetic classification of primary neurodegenerative disease. J Hardy ... K Gwinn-Hardy Science 1998 Nov; 282(5391)1075-9. Score: 0.225 Viral-induced neurodegenerative disease. M J Buchmeier ... T E Lane Curr Opin Microbiol 1999 Aug; 2(4)398-402. Score: 0.225 [Mitochondrial changes in neurodegenerative diseases] F J Jiménez-Jiménez ... J A Molina-Arjona Rev Neurol 1998 Apr; 26 Suppl 1()S112-7. Score: 0.224 Mitochondria in the life and death of neurons. S L Budd ... D G Nicholls Essays Biochem 1998 ; 33()43-52. Score: 0.224 Chronic hypothermia and water intoxication associated with a neurodegenerative disease. E L Corbett ... D Sarkar Postgrad Med J 1993 Dec; 69(818)937-40. Score: 0.224 Gene discovery and validation for neurodegenerative diseases. Peter M Mathisen Drug Discov Today 2003 Jan; 8(1)39-46. Score: 0.223 Lentiviral vectors for the treatment of neurodegenerative diseases. E Martin-Rendon ... N D Mazarakis Curr Opin Mol Ther 2001 Oct; 3(5)476-81. Score: 0.222 Brain biopsies for neurodegenerative disease in children. D L MacGregor ... L E Becker J Pediatr 1978 Jun; 92(6)903-5. Score: 0.222 Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease). H M Mitchison ... S E Mole Curr Opin Neurol 2001 Dec; 14(6)795-803. Score: 0.222 Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Peter C Waldmeier ... William G Tatton Drug Discov Today 2004 Mar; 9(5)210-8. Score: 0.222 Neuronal replacement by intracerebral neural implants in animal models of neurodegenerative disease. A Björklund ... O Isacson Adv Neurol 1988 ; 47()455-92. Score: 0.222 Alpha-synuclein aggregation and its relation to neurodegenerative diseases. Spiridon Papapetropoulos ... Deborah C Mash Ann Neurol 2005 Apr; 57(4)605; author reply 605-6. Score: 0.221 Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders. J Kelleher-Andersson J Alzheimers Dis 2004 Dec; 6(6 Suppl)S19-25. Score: 0.221 Heat shock proteins in stroke and neurodegenerative diseases. Rudolf Urbanics Curr Opin Investig Drugs 2002 Dec; 3(12)1718-9. Score: 0.221 Surgical drug delivery for neurodegenerative diseases. M G Kaplitt ... A M Lozano Clin Neurosurg 2001 ; 48()127-44. Score: 0.221 Etiology of the neurodegenerative disorders: a critical analysis. C D Rose ... R C Henneberry Neurobiol Aging 1994 Mar-Apr; 15(2)233-4. Score: 0.221 [Changes in age-associated neurodegenerative diseases in the half century] Asao Hirano Nippon Ronen Igakkai Zasshi 2003 Jan; 40(1)15-8. Score: 0.221 Cytoskeletal pathology in neurodegenerative diseases. W W Pendlebury ... D P Perl Adv Exp Med Biol 1987 ; 221()427-42. Score: 0.221 The role of environmental factors in neurodegenerative disorders. R Henneberry ... L Spatz Neurobiol Aging 1991 Jan-Feb; 12(1)75-9. Score: 0.221 Innate and acquired immunity in neurodegenerative disorders. H E Gendelman ... D G Folks J Leukoc Biol 1999 Apr; 65(4)407-8. Score: 0.221 Therapeutic effects of coenzyme Q10 in neurodegenerative diseases. M Flint Beal Methods Enzymol 2004 ; 382()473-87. Score: 0.221 Apoptosis in neurodegenerative disorders. Y Mizuno ... K Goto Intern Med 1998 Feb; 37(2)192-3. Score: 0.221 Mitochondria, neurodegenerative diseases, and selective neuronal vulnerability. J P Blass Ann N Y Acad Sci 1999 ; 893()434-9. Score: 0.221 Multiple dopamine receptors: relevance for neurodegenerative disorders. P G Strange Biochem Soc Trans 1994 Feb; 22(1)155-9. Score: 0.221 Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. D W Dickson Ann Neurol 1997 Oct; 42(4)541-4. Score: 0.221 Medicine. Treating neurodegenerative diseases with antibiotics. Timothy M Miller ... Don W Cleveland Science 2005 Jan; 307(5708)361-2. Score: 0.221 [Molecular-genetic aspects of neurodegenerative diseases with amyloid plaques] R Astarloa Neurologia 1993 Feb; 8(2)66-72. Score: 0.221 The potential for treating neurodegenerative disorders with NGF-inducing compounds. S Carswell Exp Neurol 1993 Nov; 124(1)36-42. Score: 0.221 Molecular genetics and neurobiology of neurodegenerative and neurodevelopmental disorders. H Y Zoghbi Pediatr Res 1997 May; 41(5)722-6. Score: 0.221 Mitochondrial dysfunction in neurodegenerative disorders and ageing. C Turner ... A H Schapira Adv Exp Med Biol 2001 ; 487()229-51. Score: 0.221 Therapeutic potential of NMDA antagonists in neurodegenerative diseases. R N McBurney Neurobiol Aging 1994 Mar-Apr; 15(2)271-3. Score: 0.221 Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets. Philippe Amouyel Pharmacogenomics 2002 Jan; 3(1)1-3. Score: 0.221 Neural transplantation for neurodegenerative disorders. C V Borlongan ... T B Freeman Lancet 1999 Apr; 353 Suppl 1()SI29-30. Score: 0.221 Neurodegenerative Huntington-like disorder. S Bohlega ... M Divakaran Mov Disord 2001 May; 16(3)533-4. Score: 0.221 Cancer and the dynamics of neurodegenerative processes. B Weiss Neurotoxicology 1991 ; 12(3)379-86. Score: 0.221 Cell stress genes and chronic neurodegenerative disorders. M E Cheetham Neuropathol Appl Neurobiol 1995 Dec; 21(6)486-8. Score: 0.221 NF-kappaB in neuronal plasticity and neurodegenerative disorders. M P Mattson ... S Camandola J Clin Invest 2001 Feb; 107(3)247-54. Score: 0.221 Environmental toxins and neurodegenerative diseases: a challenge for epidemiologists. Beate Ritz Epidemiology 2006 Jan; 17(1)2-3. Score: 0.221 RBD--an emerging clue to neurodegenerative disorders. Fred W Turek ... Christine Dugovic Sleep 2005 Aug; 28(8)920-1. Score: 0.221 [Therapeutic potentials of neurotrophic factors for neurodegenerative disorders] H Okazawa No To Shinkei 1996 Sep; 48(9)795-802. Score: 0.221 The pathological diagnosis of neurodegenerative diseases causing dementia. J Lowe Curr Top Pathol 2001 ; 95()149-77. Score: 0.221 Unfolding the role of protein misfolding in neurodegenerative diseases. Claudio Soto Nat Rev Neurosci 2003 Jan; 4(1)49-60. Score: 0.221 Pathogenesis of neurodegenerative disorders: the role of dynamic mutations. J B Martin Neuroreport 1996 Dec; 8(1)i-vii. Score: 0.221 [Neurotrophic factors. Therapeutic approach in neurodegenerative diseases] S Wasielewski Med Monatsschr Pharm 1992 Apr; 15(4)98-9. Score: 0.221 [Trends in diagnosis and therapy of hereditary neurodegenerative diseases] M Kuriyama Nippon Naika Gakkai Zasshi 1998 Mar; 87(3)498-502. Score: 0.221 [Synucleins--the key to mechanisms of neurodegenerative diseases?] V L Buchman Mol Biol (Mosk) 1998 Jul-Aug; 32(4)592-7. Score: 0.221 New light on polyglutamine neurodegenerative disorders: interference with transcription. C Néri Trends Mol Med 2001 Jul; 7(7)283-4. Score: 0.221 Genetic approaches to pathogenesis of neurodegenerative diseases. H T Orr ... H B Clark Lab Invest 1995 Aug; 73(2)161-71. Score: 0.221 New techniques for investigating mitochondrial DNA in neurodegenerative diseases. M F Beal Neurology 1997 Oct; 49(4)907-8. Score: 0.221 Apoptosis in neurodegenerative diseases. I Nishimoto ... T Iwatsubo Adv Pharmacol 1997 ; 41()337-68. Score: 0.221 Neurodegenerative disorders--4th annual SMi conference. Tom Phillips IDrugs 2004 Aug; 7(8)721-4. Score: 0.221 [Tau isoforms and neurodegenerative disorders] Kenji Wada ... Kenji Nakashima No To Shinkei 2002 Sep; 54(9)767-76. Score: 0.221 Nanoscale biogenic iron oxides and neurodegenerative disease. J Dobson FEBS Lett 2001 May; 496(1)1-5. Score: 0.220 Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. D A DeWitt ... G Perry Brain Res 1994 Sep; 656(1)205-9. Score: 0.220 Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency? I Ceballos ... P M Sinet Adv Exp Med Biol 1990 ; 264()493-8. Score: 0.219 [Neuropathological diagnosis of neurodegenerative and dementia diseases] H A Kretzschmar ... M Neumann Pathologe 2000 Sep; 21(5)364-74. Score: 0.219 Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments. John Q Trojanowski ... Virginia M-Y Lee Expert Opin Pharmacother 2005 May; 6(5)683-6. Score: 0.218 A palliative care approach to end-stage neurodegenerative conditions. J A Low ... R Chye Ann Acad Med Singapore 2003 Nov; 32(6)778-84. Score: 0.217 Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Leonardo Petrucelli ... Ted M Dawson Ann Med 2004 ; 36(4)315-20. Score: 0.217 Molecular mechanisms of neuronal cell death. Kim A Heidenreich Ann N Y Acad Sci 2003 Jun; 991()237-50. Score: 0.217 Subcutaneous midazolam, diamorphine and hyoscine infusion in palliative care of a child with neurodegenerative disease. D Grimshaw ... D M Hall Child Care Health Dev 1995 Nov; 21(6)377-81. Score: 0.217 Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Bin Liu ... Jau-Shyong Hong J Pharmacol Exp Ther 2003 Jan; 304(1)1-7. Score: 0.216 MAPKs: new targets for neurodegeneration. Sarah J Harper ... Neil Wilkie Expert Opin Ther Targets 2003 Apr; 7(2)187-200. Score: 0.216 Human neurodegenerative disease modeling using Drosophila. Nancy M Bonini ... Mark E Fortini Annu Rev Neurosci 2003 ; 26()627-56. Score: 0.216 Potential use of neurotrophic agents in the treatment of neurodegenerative disorders. M H Tuszyński ... F H Gage Acta Neurobiol Exp (Wars) 1990 ; 50(4-5)311-22. Score: 0.215 The role of the brain renin-angiotensin system in neurodegenerative disorders. Egemen Savaskan Curr Alzheimer Res 2005 Jan; 2(1)29-35. Score: 0.214 Neurodegenerative disease: autoimmunity involving calcium channels. S H Appel ... E Stefani Ann N Y Acad Sci 1994 Dec; 747()183-94. Score: 0.214 A national strategy for development of effective methods for the prevention and treatment of Alzheimer's disease and related neurodegenerative disorders. S B Prusiner Neurobiol Aging 1994 ; 15 Suppl 2()S29-32. Score: 0.214 The Molecular and Cellular Basis of Human Neurodegenerative Disease. Keystone symposium. Breckenridge, Colorado, April 3-9, 1995. Abstracts. J Cell Biochem Suppl 1995 ; 21B()83-113. Score: 0.214 Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Dennis W Dickson Acta Neuropathol (Berl) 2005 Jan; 109(1)14-24. Score: 0.214 Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease. J B Schulz ... M F Beal Ann N Y Acad Sci 1995 Sep; 765()100-10; discussion 116-8. Score: 0.214 Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. C L Joachim ... D J Selkoe Ann Neurol 1987 Oct; 22(4)514-20. Score: 0.213 Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Jean-François Gagnon ... Jacques Montplaisir Lancet Neurol 2006 May; 5(5)424-32. Score: 0.213 'Unfolding' pathways in neurodegenerative disease. Mark S Forman ... John Q Trojanowski Trends Neurosci 2003 Aug; 26(8)407-10. Score: 0.213 Evidence for an early inflammatory response in the central nervous system of mice with scrapie. S Betmouni ... J L Gordon Neuroscience 1996 Sep; 74(1)1-5. Score: 0.213 Drug development for neurodegenerative diseases: role of PET. J O Rinne Ann Med 1999 Dec; 31(6)444-9. Score: 0.213 In vitro models of age-related neurodegenerative disorders. André Delacourte ... Luc Buée Exp Gerontol 2003 Nov-Dec; 38(11-12)1309-17. Score: 0.212 Axonal transport defects: a common theme in neurodegenerative diseases. Subhojit Roy ... John Q Trojanowski Acta Neuropathol (Berl) 2005 Jan; 109(1)5-13. Score: 0.211 Projected neurodegenerative disease mortality in the United States, 1990-2040. D E Lilienfeld ... D P Perl Neuroepidemiology 1993 ; 12(4)219-28. Score: 0.211 The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. George Perry ... Mark A Smith CNS Drugs 2002 ; 16(5)339-52. Score: 0.210 Clinical potential of minocycline for neurodegenerative disorders. David Blum ... Marc Levivier Neurobiol Dis 2004 Dec; 17(3)359-66. Score: 0.210 Trinucleotide-repeat expansions and neurodegenerative disease: a mechanism of pathogenesis. A J Hannan Clin Exp Pharmacol Physiol 1996 Dec; 23(12)1015-20. Score: 0.210 Molecular genetics and transgenic model of Gertsmann-Sträussler-Scheinker disease. K Hsiao ... S B Prusiner Alzheimer Dis Assoc Disord 1991 ; 5(3)155-62. Score: 0.210 Neurodegenerative disorders with extensive tau pathology: a comparative study and review. M B Feany ... D W Dickson Ann Neurol 1996 Aug; 40(2)139-48. Score: 0.210 The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. G E Gibson ... N Y Calingasan Neurochem Int 2000 Feb; 36(2)97-112. Score: 0.210 Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Costantino Iadecola ... Philip B Gorelick Stroke 2003 Feb; 34(2)335-7. Score: 0.209 The role of alpha-synuclein and tau in neurodegenerative movement disorders. Gregor K Wenning ... Kurt A Jellinger Curr Opin Neurol 2005 Aug; 18(4)357-62. Score: 0.209 The diagnosis of childhood neurodegenerative disorders presenting as dementia in adults. S B Coker Neurology 1991 Jun; 41(6)794-8. Score: 0.209 [FK506-binding proteins and neurodegenerative diseases] Li-qin Zhao ... Song Li Yao Xue Xue Bao 2002 Sep; 37(9)743-8. Score: 0.209 Transgenic modelling of neurodegenerative events gathers momentum. M V Sofroniew ... K Staley Trends Neurosci 1991 Dec; 14(12)513-4. Score: 0.209 II Neurotoxicity Society Meeting. Mechanisms for neurodegenerative disorders. Richard M Kostrzewa IDrugs 2005 Jun; 8(6)469-71. Score: 0.209 High prevalence of neurovascular instability in neurodegenerative dementias. J Idiaquez ... E Sandoval Neurology 1999 Oct; 53(7)1610. Score: 0.209 Neurodegenerative diseases of infancy and childhood. (Part I). S Jain ... M C Maheshwari Indian Pediatr 1985 Oct; 22(10)767-75. Score: 0.209 GABA and glutamate receptors as therapeutic targets in neurodegenerative disorders. P Krogsgaard-Larsen Pharmacol Toxicol 1992 Feb; 70(2)95-104. Score: 0.209 Mechanisms of neurodegenerative disorders: Part 1: protein aggregates. B Wolozin ... C Behl Arch Neurol 2000 Jun; 57(6)793-6. Score: 0.209 Neurotransmitters and neurodegenerative disorders. I Kanazawa Clin Ther 1984 ; 7 Spec No()48-58. Score: 0.209 Molecular biology and genetics of neurodegenerative diseases caused by prions. S B Prusiner Adv Virus Res 1992 ; 41()241-80. Score: 0.209 Kynurenines in neurodegenerative disorders: therapeutic consideration. Péter Klivényi ... László Vécsei Adv Exp Med Biol 2004 ; 541()169-83. Score: 0.209 Familial neurodegenerative disorder associated with raised urinary VMA. A J Barson Arch Dis Child 1979 Jan; 54(1)80. Score: 0.209 The role of transglutaminases in neurodegenerative diseases: overview. Arthur J L Cooper ... John P Blass Neurochem Int 2002 Jan; 40(1)1-5. Score: 0.209 Can imaging distinguish PSP from other neurodegenerative disorders? David Eidelberg ... Vijay Dhawan Neurology 2002 Apr; 58(7)997-8. Score: 0.209 Neural grafting in animal models of neurodegenerative diseases. A Björklund ... F H Gage Ann N Y Acad Sci 1985 ; 457()53-81. Score: 0.209 Elusive roles for astrocytes in neurodegenerative disorders. M P Mattson ... E M Blanc Neurobiol Aging 1996 May-Jun; 17(3)485-7; discussion 488-90. Score: 0.209 Impaired clearance of oxidised proteins in neurodegenerative diseases. B Halliwell ... P Jenner Lancet 1998 May; 351(9114)1510. Score: 0.209 Schinzel-Giedion syndrome with severe deafness and neurodegenerative process. Y Alembik ... C Stoll Ann Genet 1999 ; 42(4)225-30. Score: 0.209 [Approaches from genetical analyses on human diseases: neurodegenerative diseases] A Kakizuka Tanpakushitsu Kakusan Koso 2000 Apr; 45(6 Suppl)792-7. Score: 0.209 Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. S E Browne ... M F Beal Biochem Soc Trans 1994 Nov; 22(4)1002-6. Score: 0.209 [Neuropsychological evaluation: a useful clinical tool for neurodegenerative diseases] R Levy Rev Neurol (Paris) 2000 Apr; 156(4)415-26. Score: 0.209 Trophic factors in neurodegenerative disorders. Joachim Weis ... Alex Kruttgen IUBMB Life 2003 Jun; 55(6)353-7. Score: 0.209 Intracerebral transplantation: prospects for neuronal replacement in neurodegenerative diseases. A Björklund Res Publ Assoc Res Nerv Ment Dis 1993 ; 71()361-74. Score: 0.209 Trace metals in human neurodegenerative diseases. E J Kasarskis ... W R Markesbery Prog Clin Biol Res 1993 ; 380()299-310. Score: 0.209 Transgenic mouse models and human neurodegenerative disorders. H X Deng ... T Siddique Arch Neurol 2000 Dec; 57(12)1695-702. Score: 0.209 When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. C A Ross Neuron 1995 Sep; 15(3)493-6. Score: 0.209 Neurodegenerative diseases of infancy and childhood. (Part II). S Jain ... M C Maheshwari Indian Pediatr 1985 Oct; 22(10)777-81. Score: 0.209 Protofibrils, the unifying toxic molecule of neurodegenerative disorders? C Haass ... H Steiner Nat Neurosci 2001 Sep; 4(9)859-60. Score: 0.209 The emerging role of infectious pathogens in neurodegenerative diseases. Dianne Langford ... Eliezer Masliah Exp Neurol 2003 Dec; 184(2)553-5. Score: 0.209 Vitamin E and neurological problems in childhood: a curable neurodegenerative process. A Kohlschütter Dev Med Child Neurol 1993 Jul; 35(7)642-6. Score: 0.209 Gene therapy for neurodegenerative diseases: fact or fiction? J E Carter ... E H Schuchman Br J Psychiatry 2001 May; 178()392-4. Score: 0.209 Occupational exposures and neurodegenerative diseases. Enrico Pira ... Elena Herrero Hernandez Epidemiology 2004 Mar; 15(2)253-4; author reply 254. Score: 0.209 Neurodegenerative disorders: George Huntington's description of hereditary chorea. Thomas C Neylan J Neuropsychiatry Clin Neurosci 2003 ; 15(1)108. Score: 0.209 Soluble oligomers for the diagnosis of neurodegenerative diseases. Omar M A El-Agnaf ... David Allsop Lancet Neurol 2003 Aug; 2(8)461-2. Score: 0.209 Computed tomography in neurodegenerative disorders in childhood. E Boltshauser ... W Isler Neuroradiology 1978 ; 16()41-3. Score: 0.209 Recent developments in animal models of human neurodegenerative diseases. C Guyer Toxicol Pathol 2000 Mar-Apr; 28(2)363-6. Score: 0.209 Screening for cognitive dysfunction in neurodegenerative illness. L McFadden ... E Mohr J Neurol Neurosurg Psychiatry 1994 Oct; 57(10)1282. Score: 0.209 Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction? Andrew N Clarkson ... Ian Appleton Curr Opin Investig Drugs 2004 Jul; 5(7)706-13. Score: 0.209 Targeting programmed cell death in neurodegenerative diseases. Miquel Vila ... Serge Przedborski Nat Rev Neurosci 2003 May; 4(5)365-75. Score: 0.209 Neurodegenerative disorders with diffuse cortical Lewy bodies. Adam S Fleisher ... John M Olichney Adv Neurol 2005 ; 96()148-65. Score: 0.209 Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040. D E Lilienfeld ... D P Perl Neuroepidemiology 1994 ; 13(4)179-86. Score: 0.208 Experimental therapeutics of neurodegenerative disorders: unmet needs. I Shoulson Science 1998 Nov; 282(5391)1072-4. Score: 0.208 Proteinaceous intracellular inclusions in neurodegenerative disorders. Dorota Dziewulska ... Janina Rafałowska Folia Neuropathol 2005 ; 43(2)51-63. Score: 0.208 [Diagnosis of neurometabolic and neurodegenerative diseases by cutaneous biopsy] M A Idoate Gastearena ... F Vega Vázquez Rev Neurol 1997 Sep; 25 Supp